Results 171 to 180 of about 579 (264)
Adaptive overcurrent protection considering fault current limiters effect. [PDF]
Mahmoud RA, Ghaly KG, Hasan SA.
europepmc +1 more source
Efficacy of Inebilizumab in N‐MOmentum Trial Participants With or Without Prior Immunosuppressants
ABSTRACT This post hoc analysis examined the impact of prior immunosuppressants on the long‐term efficacy and safety of inebilizumab, a cluster of differentiation 19+ B‐cell–depleting monoclonal antibody, in participants with aquaporin‐4–seropositive neuromyelitis optica spectrum disorder from the N‐MOmentum trial (NTC02200770).
Bruce A. C. Cree +9 more
wiley +1 more source
Design and control of LCC DVR. [PDF]
Manju AS, Manitha PV, Nair MG, Joseph A.
europepmc +1 more source
Seyyed E. Naghibi +2 more
openaire +1 more source
ABSTRACT Objective Digital technologies hold promise for transforming healthcare by enhancing personalized treatments and offer valuable opportunities to improve patient care. Here, we evaluated several novel, self‐administered, home‐based, digital endpoints for their association with corresponding conventional standard clinical measures (primary) in ...
Arne Mueller +14 more
wiley +1 more source
Hybrid Forecast-Enabled Adaptive Crowbar Coordination for LVRT Enhancement in DFIG Wind Turbines. [PDF]
Su X, Kim H, Kim C, Zhang M, Jung H.
europepmc +1 more source
ABSTRACT Objective Facioscapulohumeral muscular dystrophy (FSHD) is one of the most debilitating and common muscular dystrophies. Despite its severity, no approved therapy exists for FSHD patients. However, several therapeutic candidates are currently under development, and some have recently entered clinical trials, marking the need for reliable ...
Mustafa Bilal Bayazit +11 more
wiley +1 more source
Performance evaluation of advanced metaheuristic algorithms for directional overcurrent relay coordination in distribution networks. [PDF]
Arslanoğlu İ, Altaş İH, Kılıç H.
europepmc +1 more source
Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito +8 more
wiley +1 more source
A hybrid renewable energy system with advanced control strategies for improved grid stability and power quality. [PDF]
Slimene MB, Khlifi MA.
europepmc +1 more source

